Healthcare provider profile · identity verified

Ismael Tamba, DO

Family Practice · DURHAM, NC · NPI 1871757948

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	456	133
Hydrochlorothiazide	Hydrochlorothiazide	259	72
Losartan Potassium	Losartan Potassium	257	78
Levothyroxine Sodium	Levothyroxine Sodium	207	61
Amlodipine Besylate	Amlodipine Besylate	194	63
Rosuvastatin Calcium	Rosuvastatin Calcium	193	57
Lisinopril	Lisinopril	184	52
Metformin Hcl	Metformin Hcl	180	47
Omeprazole	Omeprazole	153	51
Metoprolol Succinate	Metoprolol Succinate	142	42
Albuterol Sulfate Hfa	Albuterol Sulfate	136	38
Pantoprazole Sodium	Pantoprazole Sodium	117	41
Tamsulosin Hcl	Tamsulosin Hcl	115	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	114	27
Pravastatin Sodium	Pravastatin Sodium	113	37
Gabapentin	Gabapentin	105	37
Simvastatin	Simvastatin	102	29
Furosemide	Furosemide	98	28
Eliquis	Apixaban	82	26
Zolpidem Tartrate	Zolpidem Tartrate	82	12
Meloxicam	Meloxicam	75	28
Montelukast Sodium	Montelukast Sodium	70	26
Carvedilol	Carvedilol	69	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	68	23
Ozempic	Semaglutide	67	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	65	17
Trazodone Hcl	Trazodone Hcl	63	19
Clopidogrel	Clopidogrel Bisulfate	62	17
Ezetimibe	Ezetimibe	62	18
Duloxetine Hcl	Duloxetine Hcl	58	12
Fluticasone Propionate	Fluticasone Propionate	56	18
Metoprolol Tartrate	Metoprolol Tartrate	56	18
Metformin Hcl Er	Metformin Hcl	55	17
Potassium Chloride	Potassium Chloride	53	16
Atenolol	Atenolol	49	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	14
Allopurinol	Allopurinol	44	13
Celecoxib	Celecoxib	44	11
Alendronate Sodium	Alendronate Sodium	42	13
Glipizide Er	Glipizide	41	13
Diclofenac Sodium	Diclofenac Sodium	40	16
Prednisone	Prednisone	38	28
Escitalopram Oxalate	Escitalopram Oxalate	37	13
Januvia	Sitagliptin Phosphate	37	suppressed
Mounjaro	Tirzepatide	37	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Glipizide	Glipizide	36	suppressed
Pregabalin	Pregabalin	36	suppressed
Sertraline Hcl	Sertraline Hcl	35	suppressed
Spironolactone	Spironolactone	35	15
Naproxen	Naproxen	34	23
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Famotidine	Famotidine	32	suppressed
Finasteride	Finasteride	32	13
Warfarin Sodium	Warfarin Sodium	32	suppressed
Lovastatin	Lovastatin	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Alprazolam	Alprazolam	27	11
Clonazepam	Clonazepam	27	suppressed
Baclofen	Baclofen	26	17
Chlorthalidone	Chlorthalidone	26	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	16
Buspirone Hcl	Buspirone Hcl	23	suppressed
Dutasteride	Dutasteride	23	suppressed
Telmisartan	Telmisartan	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	20
Xarelto	Rivaroxaban	20	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Topiramate	Topiramate	18	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Colchicine	Colchicine	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	14	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Carisoprodol	Carisoprodol	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Verapamil Hcl	Verapamil Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Ibu	Ibuprofen	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error